HUP0000476A3 - Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states - Google Patents

Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states

Info

Publication number: HUP0000476A3
Authority: HU; Hungary
Prior art keywords: betha; dihydroequilenin; treatment; pharmaceutical compositions; free radical
Prior art date: 1996-12-10

Application number

HU0000476A

Other languages

Hungarian (hu)

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-10

Filing date

1997-12-05

Publication date

2001-01-29

1997-12-05 Application filed by Wyeth Corp filed Critical Wyeth Corp

2000-10-28 Publication of HUP0000476A2 publication Critical patent/HUP0000476A2/en

2001-01-29 Publication of HUP0000476A3 publication Critical patent/HUP0000476A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

HU0000476A 1996-12-10 1997-12-05 Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states HUP0000476A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US76306596A	1996-12-10	1996-12-10
PCT/US1997/022153 WO1998025625A1 (en)	1996-12-10	1997-12-05	USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT

Publications (2)

Publication Number	Publication Date
HUP0000476A2 HUP0000476A2 (en)	2000-10-28
HUP0000476A3 true HUP0000476A3 (en)	2001-01-29

Family

ID=25066793

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0000476A HUP0000476A3 (en)	1996-12-10	1997-12-05	Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states

Country Status (13)

Country	Link
EP (1)	EP0944390A1 (en)
JP (1)	JP2001506627A (en)
KR (1)	KR20000069400A (en)
CN (1)	CN1239891A (en)
AR (1)	AR010343A1 (en)
AU (1)	AU744098C (en)
BR (1)	BR9713998A (en)
CA (1)	CA2272074A1 (en)
HU (1)	HUP0000476A3 (en)
IL (1)	IL130070A0 (en)
TW (1)	TW422693B (en)
WO (1)	WO1998025625A1 (en)
ZA (1)	ZA9711054B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030013692A1 (en) *	2001-01-19	2003-01-16	Gullans Steven R.	Methods of treating neurological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4154820A (en) *	1976-02-23	1979-05-15	Akzona Incorporated	Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
IL107343A (en) *	1992-11-02	2003-10-31	Wyeth Corp	PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US5545635A (en) *	1995-05-23	1996-08-13	Eli Lilly And Company	Inhibiting bone loss with equilenin
EP0761679A1 (en) *	1995-08-30	1997-03-12	Eli Lilly And Company	N-Butylsulfonate esters of estrogens

1997
- 1997-11-27 TW TW086117837A patent/TW422693B/en not_active IP Right Cessation
- 1997-12-05 CA CA002272074A patent/CA2272074A1/en not_active Abandoned
- 1997-12-05 IL IL13007097A patent/IL130070A0/en unknown
- 1997-12-05 BR BR9713998-0A patent/BR9713998A/en not_active IP Right Cessation
- 1997-12-05 AU AU78452/98A patent/AU744098C/en not_active Ceased
- 1997-12-05 WO PCT/US1997/022153 patent/WO1998025625A1/en not_active Ceased
- 1997-12-05 CN CN97180447A patent/CN1239891A/en active Pending
- 1997-12-05 JP JP52680398A patent/JP2001506627A/en not_active Ceased
- 1997-12-05 HU HU0000476A patent/HUP0000476A3/en unknown
- 1997-12-05 KR KR1019997005152A patent/KR20000069400A/en not_active Ceased
- 1997-12-05 EP EP97949738A patent/EP0944390A1/en not_active Withdrawn
- 1997-12-09 ZA ZA9711054A patent/ZA9711054B/en unknown
- 1997-12-09 AR ARP970105777A patent/AR010343A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR010343A1 (en)	2000-06-07
AU744098B2 (en)	2002-02-14
CN1239891A (en)	1999-12-29
EP0944390A1 (en)	1999-09-29
AU7845298A (en)	1998-07-03
HUP0000476A2 (en)	2000-10-28
AU744098C (en)	2003-07-31
CA2272074A1 (en)	1998-06-18
KR20000069400A (en)	2000-11-25
IL130070A0 (en)	2000-02-29
JP2001506627A (en)	2001-05-22
TW422693B (en)	2001-02-21
WO1998025625A1 (en)	1998-06-18
ZA9711054B (en)	1999-06-09
BR9713998A (en)	2000-02-29

Similar Documents

Publication	Publication Date	Title
IL121170A0 (en)	1997-11-20	Compositions for the treatment of dermatological disorders
IL125735A0 (en)	1999-04-11	Pharmaceutical compositions for the treatment of glaucoma
HUP9903489A3 (en)	2001-12-28	Use of epinastine for the preparation of pharmaceutical compositions treating pain
EP0808324A4 (en)	2002-03-13	Compositions and methods for the treatment and diagnosis of cardiovascular disease
SG47447A1 (en)	1998-04-17	Compositions and methods for the prevention and diagnosis of lyme disease
IL86423A0 (en)	1988-11-15	Pharmaceutical compositions for the treatment of alzheimer's disease
IL127146A0 (en)	1999-09-22	Transdermal propentofylline compositions for the treatment of alzheimer's disease
IL117656A0 (en)	1996-07-23	Pharmaceutical compositions for the treatment of travellers diarrhea
HUP9904317A3 (en)	2001-07-30	Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
IL117695A0 (en)	1996-07-23	Pharmaceutical agents for the treatment of alzheimer's disease
HUP0004331A3 (en)	2001-09-28	Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
IL117655A0 (en)	1996-07-23	Pharmaceutical compositions for the treatment of travellers diarrhea
IL121096A0 (en)	1997-11-20	Pharmaceutical compositions for the treatment of liver disease
IL113057A0 (en)	1995-06-29	Compositions for the treatment of dandruff
HUP9900309A3 (en)	1999-11-29	Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
HUP9901247A3 (en)	2000-08-28	Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
HUP0003803A3 (en)	2001-12-28	Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
GB9510162D0 (en)	1995-07-12	Compositions for the treatment of skin conditions
ZA914435B (en)	1992-03-25	Treatment of disease
IL120005A0 (en)	1997-04-15	Pharmaceutical compositions for the treatment of the eye
HUP0000569A3 (en)	2000-11-28	Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HUP0000570A3 (en)	2000-12-28	Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HUP0000476A3 (en)	2001-01-29	Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ITRM940806A0 (en)	1994-12-15	PREPARATION FOR THE TREATMENT OF OBESITY
AU4841296A (en)	1996-09-04	Diagnosis of and compositions and methods for the treatment of disease